Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Pathological Fracture Progression and Related Risk Factors for Patients With Potentially Unstable Spinal Metastases of Breast Cancer

NCT03365973 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT03365973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03365973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Pathological Fracture Progression and Related Risk Factors for Patients With Potentially Unstable Spinal Metastases of Breast Cancer
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2017
Completion date
December 15, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, spinal metastases